Background and Objectives: In patients with acute coronary syndrome, electrocardiographic parameters, including ST elevation in lead aVR (aVR-STE), ST depression (aVR-STD), and QTc prolongation, are crucial. This study aims to show the predictive value of a longer QTc in emergency department patients with acute coronary syndrome and ≥1 mm ST elevation or depression in the aVR lead in electrocardiography. Materials and Methods: A retrospective analysis was conducted on 1273 patients admitted to the emergency department with a preliminary diagnosis of acute coronary syndrome between 2020 and 2023. ST depression, ST elevation, and QTc were documented in the electrocardiography of the patients. Furthermore, acute coronary syndrome subtypes were identified. Basic demographic characteristics, complications, concomitant diseases, and 30-day and 180-day mortality data were collected. Results: The mean age of 1273 patients included in the study was 63.23 (10.06) years and 548 (43%) were female (p = 0.030). In the aVR-STE group, the QTc was 483.31 (33.96) ms in STEMI, 474.98 (26.21) ms in NSTEMI, and 505.60 (9.76) ms in those with mortality (p < 0.001). In the aVR-STD group, the QTc was 465.10 (42.63) ms in STEMI, 457.52 (39.52) ms in NSTEMI, and 508.73 (4.71) ms in those with mortality (p < 0.001). The total 30-day mortality was 129 (10.1%) and 180-day mortality was 181 (14.2%) (p < 0.001). In the uni-multivariable regression analysis performed for both change in aVR derivation and mortality, it was determined that prolonging QTc could be a predictive value for acute coronary syndrome (p < 0.001). We found sensitivity at 99.7% and specificity at 99.2% in predicting mortality in patients with prolonged QTc (AUC: 0.983, 95% CI: 0.974–0.993, p < 0.001). Conclusions: In patients with acute coronary syndrome, a prolonged QTc is an independent predictor of short- and long-term mortality in alterations in aVR derivation.

Dünyada ve Türkiye’de Antibiyotik Kullanımı Adem ÇAKIR Acil Serviste Antibiyotik Kullanımının Olumsuz Etkileri Müge ARSLAN Antibiyotiğe Bağlı İshal Patogenezi ve Neden Olan Mikroorganizmalar Özgür Deniz SADİOĞLU Disbiyozis Tarık AKDEMİR Probiyotiklerin Sınıflandırılması ve Antibiyotik İlişkili İshalin Önlenmesinde Probiyotiklerin Yeri Ramazan GÜVEN Özgür SÖĞÜT Erişkin Hastalarda Antibiyotik İlişkili İshal Yönetimi Özgür SÖĞÜT Adem AZ Çocukluk Çağı Antibiyotik İlişkili İshalde Probiyotik Kullanımı ve Güncel Öneriler Merih ÇETİNKAYA Şirin GÜVEN Yenidoğan ve Erken Bebeklik Döneminde Disbiyozis ve Önleme Stratejileri Merih ÇETİNKAYA Beslenmenin Bağırsak Mikrobiyotası Üzerine Etkisi Tuba Betül ÜMİT Mikrobiyota ve Enflamatuvar Bağırsak Hastalıkları Mücahide ŞAMLI Mustafa ÇALIK Mikrobiyata ve Gıda Alerjisi Abuzer COŞKUN Mehmet Oktay ALKAN Bağırsak Mikrobiyotası ve Gastrointestinal Kanserler Ertuğrul ALTINBİLEK Kanserlerin Önlenmesinde Probiyotiklerin Rolü Akkan AVCI Begum Şeyda AVCI Obezite ve Mikrobiyota Oğuzhan HACIOSMAN Şeyma Nur MÜLAYİM Bağırsak Mikrobiyotası ve Diyabet Özlem Canan ÖZBALTAN Mukaddes DOĞAN Cilt Bozukluklarının Tedavisinde Probiyotiklerin Önemi Serkan DOĞAN Ayşe Fethiye BASA KALAFAT Fekal Mikrobiyota Transplantasyonu Burak DEMİRCİ Burak AKIN